Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
108 participants
OBSERVATIONAL
2022-11-10
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain and Mindfulness
NCT03117478
Continuous Measurement of Glymphatic Activity in the Human Brain During Sleep-Wake States
NCT06060054
Human Brain Mapping of the Apparent Diffusion Coefficient (ADC) During Sleep and Wakefulness
NCT02311374
Studies of Blood Flow to the Brain During Thought
NCT00001360
EEG Changes With Guided Online Meditation
NCT03459690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All participants will also be asked to undergo cognitive assessments from the NIH toolbox during a video call. The assessments from the NIH toolbox will last approximately forty-five minutes to one hour.
EEG: The participants will be mailed the DREEM devices and asked to wear them for three consecutive weekday nights and two weekend nights while sleeping. During the day, for each of these five nights, meditating participants will also be asked to wear the device while they sit still with their eyes closed, without trying to meditate, for 10 minutes. This will function as the baseline waking EEG measurement. Immediately following this, participants will be asked to perform their meditation while wearing the DREEM device for a maximum of 30 minutes.
NIH Toolbox:
This study will use select tests from the NIH Toolbox Cognition Battery and from the NIH Toolbox Emotion Battery. All of the tests together will take approximately 45 minutes to 1 hour to complete.
The selected tests from the batteries are the following:
Cognition Battery
1. Picture vocabulary test
2. List sorting working memory test
3. Picture Sequence Memory test
4. Oral reading recognition test
Emotion Battery:
1. Positive Affect CAT
2. General Life Satisfaction CAT
3. Emotional Support FF
4. Instrumental Support FF
5. Friendship FF
6. Loneliness FF
7. Perceived Stress FF
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meditation
This is the group that will have learned at least Shamhbavi Mahamudra Kriya before they are enrolled in the study.
DREEM EEG Device
The DREEM EEG device will be used to measure brain age.
SleepImage Ring
The SleepImage ring uses plethysmography to analyze sleep architecture and cardiopulmonary coupling.
Control
This is the group that will not have learned Shambhavi Mahamudra Kriya before they are enrolled in the study. They will be invited to the study by the Meditation group.
DREEM EEG Device
The DREEM EEG device will be used to measure brain age.
SleepImage Ring
The SleepImage ring uses plethysmography to analyze sleep architecture and cardiopulmonary coupling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DREEM EEG Device
The DREEM EEG device will be used to measure brain age.
SleepImage Ring
The SleepImage ring uses plethysmography to analyze sleep architecture and cardiopulmonary coupling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 18 years or older.
3. Lives in the United States barring California
1. Age 18 years or older
2. Lives in the United States barring California
Exclusion Criteria
2. Night Shift workers
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beth Israel Deaconess Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Balachundhar Subramaniam
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beth Israel Deaconess Medical Centre
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022P000597
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.